Lloyd Research Centre (LRC) is a R&D hub dedicated to developing high-quality Finished Dosage Forms (FDFs) for the world’s most regulated markets, including the USA, EU, and Australia. We specialize in complex generic products across a wide spectrum of dosage forms, with core expertise in Sterile Injectables and Oral Solid Dosage Forms.

Our end-to-end services cover the entire product development lifecycle, from formulation and analytical method development to scale-up, stability testing, and technology transfer. Backed by a team of seasoned scientists and advanced infrastructure, we are a strategic partner for pharmaceutical companies seeking speed, quality, and reliability in bringing accessible therapeutics to market.